SBRA
Sabra Health Care REIT, Inc.
NasdaqGSUSDEQUITY
Real Estate
DELAYED
Neutral
-18/100
Last price
19.06
▼ 0.01 (0.05%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
19.02
Prev close
19.07
Day high
19.19
Day low
18.90
Volume
2.82M
Market cap
$4.88B
P/E (TTM)
76.48
52W range
17.17 – 22.77
Day trading desk
Gap from prior close
-0.26%
Prior close 19.07
VWAP
19.10
-0.20% from price
Relative volume
1.85×
Unusually busy
Session range
4.23%
18.90 – 19.70
Position in range
20%
Near session low
ATR (14D)
0.35
1.84% of price
Prior day high
19.37
PDH
Prior day low
18.99
PDL
Bid / ask spread
—
Quote not published
Session volume
4.91M
Avg 2.65M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.34%
-5.3%
1M
-7.99%
-9.1%
3M
-4.54%
-9.1%
6M
-4.45%
-22.6%
YTD
+0.95%
-13.3%
1Y
+5.40%
-11.0%
3Y
+37.16%
-45.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SBRA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-100.70K
Net selling
Buy transactions
29
99.30K shares
Sell transactions
1
200.00K shares
Net transactions
+30
Buys less sells
Sell : buy shares
2.0 : 1
Mixed
Insider-held shares
3.59M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 8, 26 | MATROS RICHARD K Chief Executive Officer |
SELL | 200.00K | $4.17M | Indirect |
| Aug 31, 26 | FOSTER MICHAEL JEFFREY Director |
STOCK | 791 | $0 | Direct |
| Aug 31, 26 | KATZMANN LYNNE S. Director |
STOCK | 791 | $0 | Direct |
| Aug 31, 26 | KONO ANN Director |
STOCK | 791 | $0 | Direct |
| Aug 31, 26 | COSTA MICHAEL LOURENCO Chief Financial Officer |
STOCK | 4.16K | $0 | Direct |
| Aug 31, 26 | CUSACK CATHERINE Director |
STOCK | 791 | $0 | Direct |
| Aug 31, 26 | FLORES JESSICA Officer |
STOCK | 382 | $0 | Direct |
| Aug 31, 26 | SMITH DARRIN Chief Investment Officer |
STOCK | 495 | $0 | Direct |
| Aug 31, 26 | BARBAROSH CRAIG A Director |
STOCK | 791 | $0 | Direct |
| Aug 31, 26 | MALEHORN JEFFREY A Director |
STOCK | 791 | $0 | Direct |
| Aug 31, 26 | MATROS RICHARD K Chief Executive Officer |
STOCK | 13.87K | $0 | Direct |
| Jun 17, 26 | FOSTER MICHAEL JEFFREY Director |
STOCK | 8.31K | $0 | Direct |
| Jun 17, 26 | KATZMANN LYNNE S. Director |
STOCK | 8.31K | $0 | Direct |
| Jun 17, 26 | KONO ANN Director |
STOCK | 8.31K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARBAROSH CRAIG A |
Director | 159.03K | Stock Award(Grant) |
COSTA MICHAEL LOURENCO |
Chief Financial Officer | 470.87K | Stock Award(Grant) |
CUSACK CATHERINE |
Director | 82.85K | Stock Award(Grant) |
FLORES JESSICA |
Officer | 72.48K | Stock Award(Grant) |
FOSTER MICHAEL JEFFREY |
Director | 125.25K | Stock Award(Grant) |
KATZMANN LYNNE S. |
Director | 86.91K | Stock Award(Grant) |
MALEHORN JEFFREY A |
Director | 117.14K | Stock Award(Grant) |
MATROS RICHARD K |
Chief Executive Officer | — | Sale |
NEVO-HACOHEN TALYA |
Chief Investment Officer | 869.56K | Stock Award(Grant) |
SMITH DARRIN |
Chief Investment Officer | 116.92K | Stock Award(Grant) |
Fundamentals
Market cap$4.88B
Enterprise value$7.27B
Revenue (TTM)$863.77M
Gross profit$434.20M
EBITDA$369.17M
Net income$65.44M
EPS (TTM)$0.25
Free cash flow$155.12M
Total cash$246.31M
Total debt$2.63B
Book value / share$10.77
Shares outstanding255.46M
Float251.33M
Short % of float11.28%
Dividend yield6.28%
Beta (5Y)0.62
Valuation & profitability ratios
Trailing P/E76.48
Forward P/E23.60
PEG ratio5.28
Price / sales—
Price / book1.78
EV / revenue8.42
EV / EBITDA19.70
Gross margin50.27%
Operating margin-12.53%
Profit margin7.58%
Return on equity2.39%
Return on assets1.90%
Debt / equity95.67
Current ratio3.57
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $774.63M | $703.24M | $647.51M | $624.81M | +10.2% |
| Operating revenue | $774.63M | $703.24M | $647.51M | $624.81M | +10.2% |
| Cost of revenue | $271.11M | $227.09M | $195.25M | $162.61M | +19.4% |
| Gross profit | $503.53M | $476.15M | $452.27M | $462.20M | +5.8% |
| Selling, general & admin | $53.71M | $50.07M | $47.47M | $39.57M | +7.3% |
| Total operating expense | $239.66M | $219.69M | $230.56M | $227.36M | +9.1% |
| Operating income | $263.87M | $256.46M | $221.71M | $234.84M | +2.9% |
| Net interest income | -$112.49M | -$115.27M | -$112.96M | -$105.47M | +2.4% |
| Pre-tax income | $157.35M | $127.72M | $15.76M | -$76.36M | +23.2% |
| Tax provision | $1.84M | $1.00M | $2.00M | $1.24M | +82.8% |
| Net income | $155.61M | $126.71M | $13.76M | -$77.61M | +22.8% |
| Net income to common | $155.61M | $126.71M | $13.76M | -$77.61M | +22.8% |
| Basic EPS | 0.64 | 0.54 | 0.06 | -0.34 | +18.5% |
| Diluted EPS | 0.64 | 0.54 | 0.06 | -0.34 | +18.5% |
| EBIT | $269.84M | $242.99M | $128.72M | $29.11M | +11.0% |
| EBITDA | $456.83M | $412.61M | $311.81M | $216.89M | +10.7% |
| Basic shares | 241.31M | 233.50M | 231.20M | 230.95M | +3.3% |
| Diluted shares | 244.50M | 236.05M | 232.79M | 230.95M | +3.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $71.54M | $60.47M | $41.28M | $49.31M | +18.3% |
| Cash & short-term investments | $71.54M | $60.47M | $41.28M | $49.31M | +18.3% |
| Accounts receivable | $111.29M | $131.75M | $133.81M | $147.91M | -15.5% |
| Total current assets | $189.43M | $198.09M | $180.53M | $201.84M | -4.4% |
| Goodwill & intangibles | $65.32M | $27.46M | $30.90M | $40.13M | +137.8% |
| Total assets | $5.49B | $5.30B | $5.39B | $5.75B | +3.6% |
| Total current liabilities | $336.91M | $224.45M | $231.41M | $339.24M | +50.1% |
| Current debt | $217.58M | $106.55M | $94.43M | $196.98M | +104.2% |
| Long-term debt | $2.31B | $2.31B | $2.32B | $2.31B | +0.0% |
| Total debt | $2.55B | $2.44B | $2.45B | $2.55B | +4.3% |
| Total liabilities | $2.67B | $2.56B | $2.58B | $2.69B | +4.2% |
| Retained earnings | -$2.01B | -$1.87B | -$1.72B | -$1.45B | -7.4% |
| Shareholder equity | $2.82B | $2.74B | $2.80B | $3.06B | +2.9% |
| Working capital | -$147.48M | -$26.36M | -$50.88M | -$137.40M | -459.6% |
| Net tangible assets | $2.76B | $2.71B | $2.77B | $3.02B | +1.6% |
| Shares issued | 251.70M | 237.59M | 231.27M | 231.01M | +5.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $155.51M | $126.71M | $13.76M | -$77.61M | +22.7% |
| Depreciation & amortisation | $187.00M | $169.62M | $183.09M | $187.78M | +10.2% |
| Stock-based compensation | $11.36M | $8.99M | $7.92M | $7.45M | +26.4% |
| Change in working capital | -$9.85M | -$22.55M | -$2.73M | -$19.69M | +56.3% |
| Operating cash flow | $348.61M | $310.54M | $300.57M | $315.73M | +12.3% |
| Investing cash flow | -$377.96M | -$109.00M | $103.13M | -$216.25M | -246.7% |
| Share buybacks | — | — | -$2.68M | -$4.81M | — |
| Dividends paid | -$289.50M | -$280.15M | -$277.45M | -$277.16M | -3.3% |
| Financing cash flow | $40.76M | -$181.56M | -$410.30M | -$161.71M | +122.4% |
| Free cash flow | $348.61M | $310.54M | $300.57M | $315.73M | +12.3% |
| End cash position | $78.14M | $66.34M | $46.72M | $53.93M | +17.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $235.87M | $221.75M | $211.90M | $190.04M | $189.15M | +6.4% |
| Operating revenue | $235.87M | $221.75M | $211.90M | $190.04M | $189.15M | +6.4% |
| Cost of revenue | $92.27M | $85.64M | $80.42M | $69.65M | $61.10M | +7.7% |
| Gross profit | $143.59M | $136.11M | $131.49M | $120.38M | $128.05M | +5.5% |
| Selling, general & admin | $16.82M | $14.86M | $15.91M | $12.56M | $12.51M | +13.2% |
| Total operating expense | $175.64M | $67.78M | $66.91M | $60.83M | $56.10M | +159.1% |
| Operating income | -$32.05M | $68.33M | $64.58M | $59.55M | $71.95M | -146.9% |
| Net interest income | -$29.78M | -$28.41M | -$28.94M | -$28.90M | -$27.55M | -4.8% |
| Pre-tax income | -$24.57M | $41.34M | $27.64M | $22.95M | $66.04M | -159.4% |
| Tax provision | $678.00K | $526.00K | $491.00K | $436.00K | $497.00K | +28.9% |
| Net income | -$25.20M | $40.88M | $27.23M | $22.54M | $65.54M | -161.6% |
| Net income to common | -$25.20M | $40.88M | $27.23M | $22.54M | $65.54M | -161.6% |
| Basic EPS | -0.10 | 0.16 | 0.11 | 0.09 | 0.28 | -162.5% |
| Diluted EPS | -0.10 | 0.16 | 0.11 | 0.09 | 0.27 | -162.5% |
| EBIT | $5.21M | $69.75M | $56.58M | $51.85M | $93.59M | -92.5% |
| EBITDA | $61.59M | $122.88M | $107.98M | $100.36M | $137.17M | -49.9% |
| Basic shares | 252.27M | 252.14M | 249.38M | 239.90M | 237.98M | +0.1% |
| Diluted shares | 252.27M | 255.97M | 252.77M | 243.56M | 240.93M | -1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $231.58M | $116.53M | $71.54M | $200.60M | $95.17M | +98.7% |
| Cash & short-term investments | $231.58M | $116.53M | $71.54M | $200.60M | $95.17M | +98.7% |
| Accounts receivable | $130.09M | $148.09M | $111.29M | $113.22M | $155.03M | -12.2% |
| Total current assets | $368.44M | $271.54M | $189.43M | $320.74M | $256.68M | +35.7% |
| Goodwill & intangibles | $82.95M | $67.41M | $65.32M | $59.81M | $24.65M | +23.1% |
| Total assets | $5.51B | $5.59B | $5.49B | $5.56B | $5.33B | -1.4% |
| Total current liabilities | $432.43M | $472.93M | $336.91M | $124.04M | $113.06M | -8.6% |
| Current debt | $317.48M | $354.98M | $217.58M | — | — | -10.6% |
| Long-term debt | $2.31B | $2.31B | $2.31B | $2.59B | $2.48B | -0.1% |
| Total debt | $2.65B | $2.69B | $2.55B | $2.61B | $2.50B | -1.5% |
| Total liabilities | $2.76B | $2.80B | $2.67B | $2.74B | $2.62B | -1.5% |
| Retained earnings | -$2.15B | -$2.05B | -$2.01B | -$1.96B | -$1.91B | -5.0% |
| Shareholder equity | $2.75B | $2.79B | $2.82B | $2.82B | $2.71B | -1.3% |
| Working capital | -$63.99M | -$201.39M | -$147.48M | $196.70M | $143.62M | +68.2% |
| Net tangible assets | $2.67B | $2.72B | $2.76B | $2.77B | $2.69B | -1.9% |
| Shares issued | 255.46M | 252.19M | 251.70M | 249.35M | 239.79M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$25.25M | $40.81M | $27.15M | $22.52M | $65.54M | — | -161.9% |
| Depreciation & amortisation | $56.38M | $53.13M | $51.41M | $48.51M | $43.59M | — | +6.1% |
| Stock-based compensation | $4.09M | $3.10M | $3.07M | $2.88M | $2.70M | — | +32.0% |
| Change in working capital | -$13.18M | $579.00K | -$4.26M | $8.17M | -$6.23M | — | -2,377.0% |
| Operating cash flow | $85.82M | $98.36M | $87.43M | $99.96M | $80.96M | — | -12.8% |
| Investing cash flow | $86.50M | -$105.09M | -$116.55M | -$199.84M | -$45.13M | — | +182.3% |
| Share buybacks | — | -$8.25M | — | — | — | -$5.39M | — |
| Dividends paid | -$75.66M | -$75.66M | -$74.81M | -$71.94M | -$71.38M | — | 0.0% |
| Financing cash flow | -$57.36M | $52.10M | -$100.89M | $206.17M | $36.73M | — | -210.1% |
| Free cash flow | $85.82M | $98.36M | $87.43M | $99.96M | $80.96M | — | -12.8% |
| End cash position | $238.34M | $123.45M | $78.14M | $207.52M | $101.65M | — | +93.1% |
Options analytics
Put / call volume
0.77
Call-heavy session
Put / call open interest
4.50
Positioning, not flow
Max pain
15.00
-21.5% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
+6.2%
Puts bid over calls
Call volume
31
Contracts, this expiry
Put volume
24
Contracts, this expiry
Heaviest call OI
30.00
4 contracts
Heaviest put OI
15.00
18 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.17 | 0.15 | -10.2% |
| Mar 2026 | 0.16 | 0.16 | +0.4% |
| Dec 2025 | 0.16 | 0.16 | -0.5% |
| Sep 2025 | 0.18 | 0.17 | -5.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.17 | 2 | $236.63M | +24.5% |
| Next quarter | 0.18 | 2 | $244.81M | +15.5% |
| Current year | 0.48 | 8 | $930.65M | +20.1% |
| Next year | 0.81 | 2 | $1.01B | +8.2% |
Analyst targets & ownership
Mean target$22.79
High target$25.00
Low target$19.00
Implied upside19.55%
Analyst count14
ConsensusBUY
Strong buy / Buy1 / 5
Hold10
Sell / Strong sell0 / 0
Held by insiders1.41%
Held by institutions105.29%
Institutions holding637
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
19.52
-2.35% from price
SMA 20
19.89
-3.86% from price
SMA 50
20.41
-6.32% from price
SMA 100
20.10
-5.15% from price
SMA 200
19.95
-4.16% from price
EMA 12
19.54
-2.47% from price
EMA 26
19.90
-4.22% from price
EMA 50
20.12
-5.25% from price
RSI (14)
28.7
Oversold
MACD (12,26,9)
-0.36
Hist -0.08
ATR (14)
0.35
1.83% of price
Realised vol 30D
16.2%
Annualised
Bollinger upper
20.90
20, 2σ
Bollinger lower
18.88
20, 2σ
50 / 200 cross
Golden
20.41 vs 19.95
Trend bias
Below 200
-4.16%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.17
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
16.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-16.7%
Peak to trough
Max drawdown 5Y
-38.7%
Peak to trough
ATR 14
0.35
1.83% of price
Beta (reported)
0.62
5Y monthly, from filing
Short interest
Shares short
21.02M
Prior 24.69M
Change vs prior
-14.9%
Shorts covering
% of float
11.28%
Elevated
% of shares out
8.23%
Against total outstanding
Days to cover
10.0
Crowded exit
Float
251.33M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 31, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 31, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Aug 6, 26 | Raymond James | UPGRADE | Underperform | Market Perform |
| Jul 22, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jul 22, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 22, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 8, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 8, 26 | Truist Securities | UPGRADE | Hold | Buy |
| Jul 7, 26 | Barclays | INITIATED | Equal-Weight | Equal-Weight |
| Jun 23, 26 | Citigroup | DOWNGRADE | Buy | Neutral |
| Jun 18, 26 | Scotiabank | MAINTAINED | Sector Perform | Sector Perform |
| Jun 1, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$1.20 / yr
Forward yield6.28%
5-year avg yield7.62%
Payout ratio480.00%
Ex-dividend dateAug 14, 2026
Next pay dateAug 31, 2026
Last split1:3
Split dateNov 16, 2010
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-06-17
Corporate Changes & Voting Matters
8-K · 2026-05-28
Periodic Financial Reports
10-Q · 2026-04-29
Proxy Statements
DEFA14A · 2026-04-24
Periodic Financial Reports
10-K · 2026-02-12
Corporate Changes & Voting Matters
8-K · 2026-01-05
Corporate Changes & Voting Matters
8-K · 2025-11-05
Headlines
Huntington Initiates Sabra Health Care REIT at Outperform With $23 Price Target
MT Newswires · 27d ago
Sabra Health Care Insider Sold Shares Worth $4,166,000, According to a Recent SEC Filing
MT Newswires · 27d ago
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference
Business Wire · 28d ago
Inflation and Taxes Are Eating Into Your Savings. What You Can Do About It.
Barrons.com · 54d ago
Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript
Motley Fool · 57d ago
Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More
24/7 Wall St. · 62d ago
Raymond James Upgrades Sabra Health Care REIT to Market Perform From Underperform
MT Newswires · 62d ago
Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation
Simply Wall St. · 62d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.